HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Nakamura Selected Research

VEP-THP protocol

7/2001[CHF arising after low dose THP-COP chemotherapy in an elderly patient with malignant lymphoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Nakamura Research Topics

Disease

77Neoplasms (Cancer)
12/2021 - 01/2000
19Neoplasm Metastasis (Metastasis)
02/2021 - 01/2000
19Lymphoma (Lymphomas)
02/2011 - 03/2000
14Infections
05/2019 - 02/2000
11Breast Neoplasms (Breast Cancer)
01/2020 - 07/2000
10Colorectal Neoplasms (Colorectal Cancer)
03/2004 - 03/2000
9Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2000
9Carcinoma (Carcinomatosis)
12/2014 - 01/2000
9Hemorrhage
07/2014 - 01/2000
8Alzheimer Disease (Alzheimer's Disease)
01/2015 - 02/2000
8Atrophy
02/2013 - 12/2000
7B-Cell Lymphoma (Lymphoma, B Cell)
12/2015 - 04/2000
7Myocardial Infarction
12/2001 - 09/2000
6Colonic Neoplasms (Colon Cancer)
11/2022 - 03/2000
6Thrombosis (Thrombus)
12/2021 - 01/2000
6Parkinson Disease (Parkinson's Disease)
09/2013 - 03/2000
6Body Weight (Weight, Body)
09/2013 - 12/2000
6Leukemia
10/2000 - 01/2000
5Inflammation (Inflammations)
10/2014 - 02/2000
5Hypertension (High Blood Pressure)
07/2013 - 02/2000
5Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2011 - 09/2000
5Atherosclerosis
11/2007 - 05/2000
5Acute Promyelocytic Leukemia
03/2003 - 06/2000
5Stomach Neoplasms (Stomach Cancer)
03/2002 - 07/2000
5Chest Pain (Chest Pains)
10/2001 - 05/2000
4Squamous Cell Carcinoma of Head and Neck
02/2021 - 09/2005
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2019 - 03/2000
4Multiple Myeloma
01/2015 - 07/2001
4Fibrosis (Cirrhosis)
10/2014 - 11/2000
4Ulcerative Colitis
08/2013 - 05/2000
4Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2012 - 02/2001
4T-Cell Lymphoma (Lymphoma, T Cell)
02/2011 - 10/2000
4Crohn Disease (Crohn's Disease)
10/2005 - 12/2000
4Diabetes Mellitus
09/2004 - 09/2000
4Adenoma (Adenomas)
04/2003 - 03/2000
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2002 - 04/2000
4Aneuploidy (Aneuploid)
12/2001 - 08/2000
4Multiple System Atrophy
11/2001 - 03/2000
4Heart Failure
07/2001 - 01/2000
3Immunoglobulin G4-Related Disease
07/2019 - 10/2017
3Proteinuria
05/2019 - 09/2000
3Essential Hypertension
07/2013 - 11/2007
3Ulcer
02/2013 - 01/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012 - 05/2000

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2000
9Immunoglobulin G (IgG)IBA
03/2015 - 12/2000
9DNA (Deoxyribonucleic Acid)IBA
01/2006 - 01/2000
8Biological ProductsIBA
12/2021 - 10/2000
8Messenger RNA (mRNA)IBA
01/2017 - 03/2000
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013 - 01/2000
8AntigensIBA
07/2006 - 07/2000
6CytokinesIBA
03/2015 - 10/2006
6EnzymesIBA
10/2014 - 07/2000
6Pharmaceutical PreparationsIBA
10/2014 - 01/2000
6Fluorouracil (Carac)FDA LinkGeneric
11/2013 - 05/2000
6Insulin (Novolin)FDA Link
09/2013 - 11/2000
6Thromboplastin (Tissue Factor)IBA
10/2001 - 01/2000
5Amyloid (Amyloid Fibrils)IBA
01/2015 - 05/2000
5Rituximab (Mabthera)FDA Link
07/2011 - 06/2002
5Capsules (Microcapsules)IBA
02/2007 - 09/2000
5Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2005 - 12/2000
5Anti-Bacterial Agents (Antibiotics)IBA
01/2003 - 02/2000
5Indicators and Reagents (Reagents)IBA
10/2001 - 01/2000
5Doxorubicin (Adriamycin)FDA LinkGeneric
06/2001 - 09/2000
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2021 - 03/2001
4Peptides (Polypeptides)IBA
04/2019 - 01/2000
4Docetaxel (Taxotere)FDA Link
01/2017 - 10/2005
4Phenobarbital (Luminal)FDA Link
03/2016 - 01/2000
4AutoantibodiesIBA
10/2014 - 01/2000
4Adrenal Cortex Hormones (Corticosteroids)IBA
10/2014 - 05/2000
4Biomarkers (Surrogate Marker)IBA
11/2013 - 01/2001
4LipidsIBA
07/2013 - 04/2000
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2013 - 03/2000
4Monoclonal AntibodiesIBA
07/2009 - 01/2000
4Granzymes (Granzyme)IBA
04/2008 - 10/2000
4Keratins (Keratin)IBA
05/2007 - 07/2000
4DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
07/2006 - 12/2000
4AntibodiesIBA
05/2006 - 03/2000
4CyclinsIBA
09/2003 - 04/2000
4Cyclin D1IBA
10/2001 - 04/2000
4AldosteroneIBA
07/2001 - 09/2000
3AlbuminsIBA
12/2021 - 12/2000
3GlucocorticoidsIBA
05/2019 - 03/2000
3InterleukinsIBA
10/2017 - 06/2001
3Complementary DNA (cDNA)IBA
10/2017 - 02/2001
3Oxygen (Dioxygen)IBA
01/2017 - 09/2000
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2014 - 09/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 09/2000
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2013 - 02/2004
3AnthracyclinesIBA
07/2011 - 01/2000

Therapy/Procedure

45Therapeutics
01/2022 - 01/2000
22Drug Therapy (Chemotherapy)
06/2017 - 01/2000
8Ligation
06/2005 - 01/2000
5Radiotherapy
06/2006 - 02/2000
5Osteotomy
03/2001 - 01/2000
4Aftercare (After-Treatment)
05/2019 - 02/2000
4Renal Dialysis (Hemodialysis)
11/2006 - 05/2000
4Gastrectomy
09/2001 - 10/2000
4Transplantation
01/2001 - 01/2000
3Adjuvant Chemotherapy
01/2020 - 10/2000